Soleno Therapeutics Inc
NASDAQ:SLNO

Watchlist Manager
Soleno Therapeutics Inc Logo
Soleno Therapeutics Inc
NASDAQ:SLNO
Watchlist
Price: 76.7 USD -0.1% Market Closed
Market Cap: 3.8B USD

Intrinsic Value

SLNO's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one SLNO stock under the Base Case scenario is 113.36 USD. Compared to the current market price of 76.7 USD, Soleno Therapeutics Inc is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SLNO Intrinsic Value
113.36 USD
Undervaluation 32%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Soleno Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
SLNO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for SLNO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Soleno Therapeutics Inc
NASDAQ:SLNO
US
Biotechnology
Market Cap
3.5B USD
IPO
Oct 23, 2014
US
Biotechnology
Market Cap
3.5B USD
IPO
Oct 23, 2014
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Soleno Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Soleno Therapeutics Inc

Current Assets 293.9m
Cash & Short-Term Investments 291.4m
Other Current Assets 2.5m
Non-Current Assets 37.1m
Long-Term Investments 27.2m
PP&E 3m
Intangibles 6.8m
Other Non-Current Assets 83k
Efficiency

Free Cash Flow Analysis
Soleno Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Soleno Therapeutics Inc

Revenue
0 USD
Operating Expenses
-187.7m USD
Operating Income
-187.7m USD
Other Expenses
11.8m USD
Net Income
-175.9m USD
Fundamental Scores

SLNO Profitability Score
Profitability Due Diligence

Soleno Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score

Soleno Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

SLNO Solvency Score
Solvency Due Diligence

Soleno Therapeutics Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
86/100
Solvency
Score

Soleno Therapeutics Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SLNO Price Targets Summary
Soleno Therapeutics Inc

Wall Street analysts forecast SLNO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SLNO is 107.67 USD with a low forecast of 81.81 USD and a high forecast of 152.25 USD.

Lowest
Price Target
81.81 USD
7% Upside
Average
Price Target
107.67 USD
40% Upside
Highest
Price Target
152.25 USD
99% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Soleno Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SLNO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SLNO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SLNO stock?

The intrinsic value of one SLNO stock under the Base Case scenario is 113.36 USD.

Is SLNO stock undervalued or overvalued?

Compared to the current market price of 76.7 USD, Soleno Therapeutics Inc is Undervalued by 32%.

Back to Top